Microecological control of antimicrobial resistance using CRISPR-based precision interventions

Read full text
Authors: Karthik K. Karunakar, Prabakaran, Jayashree, Sowmiya Philip, Kunal R. Kataria
Cited by: 3
References: 118

Abstract

Conventional antimicrobial treatment is limited by genetically active reservoirs of resistomes in humans that propagate antimicrobial resistance genes regardless of antibiotic dosage. Interconnected microbiomes gather, spread, and protect resistance genes, making antimicrobial resistance a potential global issue. Broad-spectrum antibiotics disrupt microbial ecology, increase selective pressure, and hasten horizontal gene transfer, hence augmenting genetic resistance. Maintaining the health of microbial populations is crucial while managing resistance factors. This unique CRISPR-Cas-based technique for controlling antimicrobial resistance focuses on resistance genes, virulence factors, and mobile genomic elements while keeping bacteria alive. Our current study explores that native CRISPR immunity reduces plasmid acquisition and resistome expansion; yet, many clinically effective infections lack functional CRISPR systems, suggesting an evolutionary trade-off that favors resistance over immune defense. This ecological perspective guides our critical evaluation of engineered CRISPR-based antimicrobials administered by bacteriophages, conjugative plasmids, nanoparticles, and engineered probiotics to eradicate resistance plasmids, resensitize multidrug-resistant infections, and reduce pathogenicity. Mechanistic and in vivo studies have shown that CRISPR lowers the resistance load and escape pressure in Enterobacteriaceae, Pseudomonas aeruginosa, Staphylococcus aureus, and viruses. The hurdles in designing CRISPR include poor microbiome ecology, delivery effectiveness, anti-CRISPR mechanisms, and transmission through mobilome. Our microecological framework employs CRISPR technologies as resistome-modulating adjuvants to maintain antibiotic efficacy, rather than relying solely on antimicrobials. CRISPR-based medicines revolutionize how antibiotic resistance is regulated considering AMR possesses been linked with genetic flow and ecological balance.

Fields of Study & Subjects

CRISPR and Genetic Engineering bioluminescence and chemiluminescence research Pharmaceutical and Antibiotic Environmental Impacts

Publication details

Journal / source
Medicine in Microecology
Publisher
Elsevier BV
Volume
28
Pages
100173–100173
Publication date
28 March 2026
Language
EN